NCT02003222 2026-05-01Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting488 enrolled 13 charts 1 FDA